Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Response to "Glucocorticoids for treating Takotsubo syndrome?" and "Atypical global Takotsubo syndrome in a patient with acute disseminated encephalomyelitis".
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past.
Biologics at Novartis
Teva and Takeda announce agreement for glatiramer acetate for multiple sclerosis treatment in Japan
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
Severe haematological complications during treatment with natalizumab.
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?
[Vitamin D for prevention of diseases?].
Plasma exchange in severe attacks of neuromyelitis optica.
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
[Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report].
Modulation of Sox10, HIF-1α, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult.
Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis.
On dihydroorotate dehydrogenases, their inhibitors and uses.
Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide.
Solodyn

Pages